| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/27/1995 | US5428175 Antitumor agent; antimicrobial agent; side effect reduction |
| 06/27/1995 | US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
| 06/27/1995 | CA1336089C 4-oxo-1,4-dihydro-quinoline-3-carboxylic acid derivatives as antibacterial agents |
| 06/27/1995 | CA1336088C 1-(3'-substitued-2', 3'-dideoxy-d-ribofuranosyl) thymine and uracil |
| 06/22/1995 | WO1995016915A1 METHODS AND MATERIALS FOR THE DETECTION OF $i(STAPHYLOCOCCUS AUREUS) |
| 06/22/1995 | WO1995016784A1 Human interferon expression vectors for treating aids |
| 06/22/1995 | WO1995016696A2 Modified oligonucleotides, method for producing them and use as active substances |
| 06/22/1995 | WO1995016694A1 Origin of replication complex genes, proteins and methods |
| 06/22/1995 | WO1995016688A1 Hiv protease inhibitors |
| 06/22/1995 | WO1995016680A1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| 06/22/1995 | WO1995016461A1 PROBIOTIC FOR CONTROL OF $i(SALMONELLA) |
| 06/22/1995 | WO1995016437A1 Method of transmitting a biologically active material to a cell |
| 06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 06/22/1995 | WO1995007987A3 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 06/22/1995 | WO1995003407A3 Oligonucleotides with activity against human immunodeficiency virus |
| 06/22/1995 | CA2179149A1 Methods and materials for the detection of staphylococcus aureus |
| 06/22/1995 | CA2178965A1 Origin of replication complex genes, proteins and methods |
| 06/22/1995 | CA2178192A1 Probiotic for control of salmonella |
| 06/22/1995 | CA2155568A1 Human interferon expression vectors for treating aids |
| 06/21/1995 | EP0658558A1 Separation of cephalosporin isomers |
| 06/21/1995 | EP0658166A1 Antiviral pyrimidine nucleosides |
| 06/21/1995 | EP0658162A1 Carbapenem derivatives and processes for preparing the same |
| 06/21/1995 | EP0658158A1 4-hydroxy coumarin derivatives with antibacterial activity |
| 06/21/1995 | EP0658119A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 06/21/1995 | EP0658118A1 Vaccines against group c neisseria meningitidis |
| 06/21/1995 | EP0658110A1 Use of norastemizole for the treatment of allergic disorders |
| 06/21/1995 | EP0658109A1 Metallo porphyrin compositions |
| 06/21/1995 | EP0631472A4 Antiviral contraceptive devices, particularly condoms. |
| 06/21/1995 | EP0540547B1 Prophylactic and therapeutic applications of peroxidases |
| 06/21/1995 | CN1028990C Hiv-inhibiting benzeneacetamide derivatives |
| 06/20/1995 | US5426104 Bactericides |
| 06/15/1995 | WO1995016054A1 Identification of novel drugs and reagents |
| 06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
| 06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 06/15/1995 | WO1995015966A1 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antidegenerative agents |
| 06/15/1995 | WO1995015965A1 Novel quinolone compounds and processes for the preparation thereof |
| 06/15/1995 | WO1995015949A1 Tricyclic derivatives and their use in pharmaceuticals |
| 06/15/1995 | WO1995015939A1 Tricyclic derivatives, pharmaceutical compositions containing them |
| 06/15/1995 | WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 06/15/1995 | WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 06/15/1995 | WO1995014014A3 Pyrone derivatives as protease inhibitors and antiviral agents |
| 06/15/1995 | CA2178492A1 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antidegenerative agents |
| 06/15/1995 | CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 06/15/1995 | CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof |
| 06/15/1995 | CA2176825A1 C5a receptor antagonists having substantially no agonist activity |
| 06/14/1995 | EP0657468A1 Human stromae derived factor |
| 06/14/1995 | EP0657465A2 Liponucleotide compounds |
| 06/14/1995 | EP0657464A1 9a-N-(N'-Carbamoyl) and 9a-N-(N'-Thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A |
| 06/14/1995 | EP0657449A1 Azole compounds, their production and use as antifungal agents |
| 06/14/1995 | EP0657167A2 Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum |
| 06/14/1995 | EP0657166A1 Combination containing a quinoxaline and a nucleoside |
| 06/14/1995 | EP0656952A1 Cationic peptides and method for production |
| 06/14/1995 | EP0656950A1 Tat-derived transport polypeptides |
| 06/14/1995 | EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE |
| 06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
| 06/14/1995 | EP0656945A1 Stress protein epitopes |
| 06/14/1995 | EP0656942A1 Compositions and methods for inhibiting growth or replication of viruses |
| 06/14/1995 | EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 06/14/1995 | EP0656900A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| 06/14/1995 | EP0656899A1 Condensed carbapenem derivatives |
| 06/14/1995 | EP0656888A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/14/1995 | EP0656887A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/14/1995 | EP0656790A1 Compositions and methods for modulating rna |
| 06/14/1995 | EP0656788A1 Hla binding peptides and their uses |
| 06/14/1995 | EP0656785A1 Method for inhibiting hiv replication using il-4 |
| 06/14/1995 | EP0656778A1 ENANTIOMERICALLY PURE $g(b)-D-DIOXOLANE-NUCLEOSIDES |
| 06/14/1995 | EP0569457B1 Use of thiazolo-[2,3-a]isoindole derivatives as antiviral medicaments and novel thiazolo- [2,3-a]isoindole derivatives |
| 06/13/1995 | US5424426 Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type |
| 06/13/1995 | US5424416 Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides |
| 06/13/1995 | US5424396 Containing three to six amino acids |
| 06/13/1995 | US5424395 Antimicrobial peptides active against plant pathogens |
| 06/13/1995 | US5424315 Treating herpes viral infections, particularly cytomegalovirus |
| 06/13/1995 | US5424311 A viricides for treating viral diseases; HIV enzyme inhibitor |
| 06/13/1995 | US5424306 Crystalline carbapenem derivative |
| 06/13/1995 | US5424295 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine |
| 06/13/1995 | US5424290 Amphiphilic polypeptide containing 21 to 26 amino acids inhibits growth of target cells, viruses and virally-infected cells |
| 06/13/1995 | US5424078 Aqueous ophthalmic formulations and methods for preserving same |
| 06/13/1995 | US5424069 Production of crystalline penem |
| 06/13/1995 | US5424066 Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells |
| 06/13/1995 | US5424063 Aids therapy |
| 06/13/1995 | CA1335892C Saccharide derivatives |
| 06/10/1995 | CA2137605A1 Combination preparations comprising a quinoxaline and a nucleoside |
| 06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | WO1995015336A1 Double-chain hemoregulatory peptides |
| 06/08/1995 | WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | WO1995015326A1 Novel indole or salt thereof |
| 06/08/1995 | WO1995015324A1 Substituted aminoalkylaminopyridines |
| 06/08/1995 | WO1995015311A1 Tachykinin antagonists |
| 06/08/1995 | WO1995015309A1 Dp-iv-serine protease inhibitors |
| 06/08/1995 | WO1995015179A1 Method of treating intestinal disorders |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995013071A3 Treatment of immunoregulatory disorders |
| 06/08/1995 | CA2617836A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | CA2178066A1 Dp-iv-serine protease inhibitors |
| 06/08/1995 | CA2178000A1 Substituted aminoalkylaminopyridines |
| 06/08/1995 | CA2177994A1 Tachykinin antagonists |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177570A1 Method of treating intestinal disorders |
| 06/07/1995 | EP0656364A1 Erythromycin derivatives, their process of preparation and their use as medicaments |